|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DRRX
|
DURECT Corporation
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|
|
NERV
|
Minerva Neurosciences, Inc
|
US
|
NASDAQ
|
|
OMER
|
Omeros Corporation
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
TTNP
|
Titan Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
US
|
NASDAQ
|